PerkinElmer has developed assay technologies, microplates, multi-mode plate readers and Imaging instrumentation + reagents for Drug Discovery research. The HTRF and AlphaLISA homogeneous, orthogonal assay platforms are robust, flexible and can be applied to a large range of drug targets within Infection Biology for small and large molecule drug research. This presentation highlights:
Homogeneous assays for: viral antigen quantification detecting immune-response e.g. cytokine release + phospho-protein signalling assays virus:host interaction e.g. Biochemical PPI assays for COVID-19 therapeutic discovery anti-viral antibodies
